Back to
UBS Group AG
ANIP30 quarters
Position history for
UBS Group AG's holdings in Ani Pharmaceuticals Inc
Yes. Ubs holds 297,539 shares of ANIP (Ani Pharmaceuticals), worth $24.6M, as of its Q2 2026 13F filing. It reduced the position by 200,163 shares (-40.2%) from Q1 2026. Ubs has held ANIP since Q3 2022, across 16 quarterly 13F filings.
Current Value
$24.6M
Current Shares
297,539
Total Value Change
+$24.6M
Total Shares Change
+297,419
Quarter-by-Quarter History
Other major holders of ANIP: BlackRock, Inc.